By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Otonomy, Inc. 

6275 Nancy Ridge Drive
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-242-5200 Fax: 858-200-0933


Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address diseases of the inner and middle ear. There are no drugs currently approved by the FDA for the lead indications we are currently pursuing for our product candidates. Our lead candidate AuriPro completed Phase 3 clinical trials in pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery, and we have submitted a request to the FDA for approval. If approved, we anticipate a commercial launch in early 2016 and are building our business and commercial team to meet the needs of this next stage of our growth.

Key Statistics

Ownership: Public

Web Site: Otonomy
Symbol: OTIC


Company News
Otonomy (OTIC) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/3/2017 8:50:26 AM
Otonomy (OTIC) To Report Fourth Quarter And Full Year 2016 Financial Results And Provide Corporate Update 2/24/2017 8:05:29 AM
Otonomy (OTIC) Release: Company Initiates Patient Enrollment In Phase II Clinical Trial Of OTO-104 As Protectant Against Cisplatin-Induced Hearing Loss 1/19/2017 7:08:13 AM
Otonomy (OTIC) Provides Corporate And Product Pipeline Update 1/9/2017 8:08:47 AM
Otonomy (OTIC) Announces Positive Top-Line Results From Phase III Clinical Trial of OTIPRIO in Patients With Acute Otitis Externa 1/5/2017 8:09:14 AM
Otonomy (OTIC) Appoints Kathie M. Bishop, Ph.D., as Chief Scientific Officer 12/1/2016 7:52:47 AM
Otonomy (OTIC) Third Quarter 2016 Financial Results And Provides Corporate Update 11/4/2016 9:18:05 AM
Otonomy (OTIC) Announces Assignment Of J Code For OTIPRIO 11/2/2016 7:56:53 AM
Otonomy (OTIC) To Report Third Quarter 2016 Financial Results And Provide Corporate Update 10/28/2016 8:48:00 AM
Otonomy (OTIC) Holds Investor And Analyst Day And Provides Corporate Update 10/7/2016 8:09:25 AM